Some researchers in America said on Wednesday that they have discovered a way to attack late-stage cancer tumours. This can be done by attaching a potent chemotherapy drug to tiny carbon particles aka nanodiamonds.
It was first experimented on mice and it was evident that the nanodiamonds assisted the drug called doxorubicin to enter the tumour, usually resistant to chemo, and shrink it.
In the absence of the nanodiamonds, the body rejected the drug and there was no effect on the tumour or it was far too strong for patients to survive in larger amounts of doses.
This research is promising because there is a possibility to use it in humans as chemotherapy drug resistance normally causes treatment to fail in most cancers that have reached the later stages.
It was shown that those animals which consumed a higher dosage could not withstand the force that they all perished before the study concluded. However, when doing it with nanodiamonds, all survived and the tumour sizes were the smallest in the entire research.
It was first experimented on mice and it was evident that the nanodiamonds assisted the drug called doxorubicin to enter the tumour, usually resistant to chemo, and shrink it.
In the absence of the nanodiamonds, the body rejected the drug and there was no effect on the tumour or it was far too strong for patients to survive in larger amounts of doses.
This research is promising because there is a possibility to use it in humans as chemotherapy drug resistance normally causes treatment to fail in most cancers that have reached the later stages.
It was shown that those animals which consumed a higher dosage could not withstand the force that they all perished before the study concluded. However, when doing it with nanodiamonds, all survived and the tumour sizes were the smallest in the entire research.
No comments:
Post a Comment